Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Salivary Gland Neoplasms 1 Recurrence 1 Nasopharyngeal Carcinoma 1 Head and Neck Neoplasms 1

Interventions

Cisplatin 51 Gemcitabine 24 Radiotherapy, Intensity-Modulated 21 Docetaxel 20 Fluorouracil 15 camrelizumab 12 Drug Therapy 11 Radiotherapy 10 toripalimab 8 Chemoradiotherapy 8 Capecitabine 8 apatinib 7 Induction Chemotherapy 7 nimotuzumab 6 endostar protein 6 Endostatins 6 sintilimab 5 nedaplatin 5 Bevacizumab 5 fludarabine 4 Cyclophosphamide 4 spartalizumab 3 fludarabine phosphate 3 cisplatin-guanosine adduct 3 SSRP1 protein, human 3 Paclitaxel 3 Injections 3 Endoscopy 3 tislelizumab 2 Vitamin B 12 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Nasopharyngeal Carcinoma × temoporfin × Clear all

NCT01086488 2011-07-08

FOSCAN

Ministry of Health, Malaysia

Phase 2 Unknown

Nasopharyngeal Carcinoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡